News + Filings Key Docs Transactions Holdings Ownership
|
Emerald Health Sciences Inc. (EMHTF)
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 02/22/2023 | Skye Bioscience, Inc. | NMUS | Grant | Common Stock | 16.6M | $0.02 | $282.9k | | 11/10/2022 |
| 02/22/2023 | Skye Bioscience, Inc. | NMUS | Grant | Common Stock | 41.4M | $0.04 | $1.6M | | 11/10/2022 |
| 02/22/2023 | Skye Bioscience, Inc. | NMUS | Disposition | Warrants | 9.1M | $0.02 | $155.4k | | 11/10/2022 |
| 02/22/2023 | Skye Bioscience, Inc. | NMUS | Purchase | Warrants with Credit Facility of Oct 5, 2018 | 2.5M | $0.04 | $96.5k | | 11/10/2022 |
| 02/22/2023 | Skye Bioscience, Inc. | NMUS | Disposition | Warrants with Credit Facility of Oct 5, 2018 - T3 | 2.5M | $0.04 | $96.5k | | 11/10/2022 |
| 11/10/2022 | Skye Bioscience, Inc. | NMUS | Other (acquisition) | Warrants | 9.1M | $0.15 | $1.4M | | 11/10/2022 |
| 08/07/2020 | Skye Bioscience, Inc. | NMUS | Sale | Common Stock | 3M | $0.10 | $300k | | 08/07/2020 |
| 08/07/2020 | Skye Bioscience, Inc. | NMUS | Sale | Common Stock | 2.6M | $0.10 | $256.7k | | 08/07/2020 |
| 12/20/2019 | Skye Bioscience, Inc. | NMUS | Other (disposition) | 7% Convertible Debt | 4.1M | $0.40 | $1.6M | | 12/20/2019 |
| 12/20/2019 | Skye Bioscience, Inc. | NMUS | Other (disposition) | Warrant(Right to Buy) | 40.8M | $0.10 | $4.1M | | 12/20/2019 |
| 12/20/2019 | Skye Bioscience, Inc. | NMUS | Other (acquisition) | Common Stock | 40.8M | $4,080,000.00 | $166464000M | | 12/20/2019 |
| 03/29/2019 | Skye Bioscience, Inc. | NMUS | Other (acquisition) | Warrant (Right to Buy) | 2.5M | $0.50 | $1.2M | | 03/29/2019 |
| 03/29/2019 | Skye Bioscience, Inc. | NMUS | Other (acquisition) | 7% Convertible Debt | 2M | $0.40 | $800k | | 03/29/2019 |
| 02/01/2019 | Skye Bioscience, Inc. | NMUS | Other (acquisition) | Warrant (Right to Buy) | 2.5M | $0.50 | $1.2M | | 02/01/2019 |
| 02/01/2019 | Skye Bioscience, Inc. | NMUS | Other (acquisition) | 7% Convertible Debt | 0 | $0.40 | $0 | | 02/01/2019 |
| 12/27/2018 | Skye Bioscience, Inc. | NMUS | Other (acquisition) | Common Stock | 37.7k | $0.00 | $0 | | 12/27/2018 |
| 11/01/2018 | Skye Bioscience, Inc. | NMUS | Other (acquisition) | Warrant (Right to Buy) | 2.5M | $0.50 | $1.2M | | 11/01/2018 |
| 11/01/2018 | Skye Bioscience, Inc. | NMUS | Other (acquisition) | 7% Convertible Debt | 0 | $0.40 | $0 | | 11/01/2018 |
| 03/29/2018 | Skye Bioscience, Inc. | NMUS | Conversion | Common Stock | 12.3M | $0.10 | $1.2M | | 03/29/2018 |
| 03/29/2018 | Skye Bioscience, Inc. | NMUS | Conversion | Common Stock | 20M | $0.10 | $2M | | 03/29/2018 |
| 03/29/2018 | Skye Bioscience, Inc. | NMUS | Conversion | Series B Convertible Preferred Stock | 1.2k | $0.10 | $123.4 | | 03/29/2018 |
| 03/29/2018 | Skye Bioscience, Inc. | NMUS | Conversion | Series F Convertible Preferred Stock | 2k | $0.10 | $200 | | 03/29/2018 |
| 02/16/2018 | Skye Bioscience, Inc. | NMUS | Purchase | Common Stock Warrants (right to buy) | 20.4M | $0.10 | $2M | | 02/16/2018 |
| 02/16/2018 | Skye Bioscience, Inc. | NMUS | Purchase | Common Stock | 15M | $0.00 | $0 | | 02/16/2018 |
| 01/24/2018 | Skye Bioscience, Inc. | NMUS | Exercise (in-the-money or at-the-money) | Common Stock Warrant (Right to Buy) | 1.8M | $0.00 | $1.8k | | 01/24/2018 |
|